Small Animal Imaging Reagents Sales

Small Animal Imaging Reagents Sales Market Outlook

The global Small Animal Imaging Reagents market was valued at approximately USD 1.5 billion in 2023 and is projected to reach around USD 2.8 billion by 2035, growing at a CAGR of 8.1% during the forecast period. This growth can be attributed to the rising prevalence of chronic diseases and the increasing demand for advanced imaging techniques in preclinical research. The market is also influenced by the growing emphasis on personalized medicine, which necessitates the use of precise imaging reagents for effective diagnosis and treatment strategies. Furthermore, the expansion of research activities in the fields of oncology, neurology, and cardiology is expected to drive the demand for small animal imaging reagents, as they play a crucial role in understanding disease mechanisms and evaluating therapeutic efficacy. Additionally, technological advancements in imaging modalities and reagents are anticipated to further enhance market growth.

Growth Factor of the Market

The growth of the Small Animal Imaging Reagents market is significantly driven by advancements in imaging technologies and the increasing investments in research and development across various sectors. As preclinical studies become integral to the drug development process, the demand for reliable and efficient imaging reagents has surged. Furthermore, the rising focus on cancer research has propelled the need for specialized reagents that facilitate the monitoring of tumor dynamics in animal models. The expanding applications of molecular imaging in studying neurological disorders also contribute to market expansion. In addition, the growing adoption of non-invasive imaging techniques is increasingly preferred by researchers for ethical reasons, leading to heightened demand for small animal imaging reagents. These factors collectively drive the market towards sustainable growth over the coming years.

Key Highlights of the Market

• Significant growth in the demand for optical imaging reagents due to their non-invasive nature.
• Increased focus on oncology applications, particularly in preclinical drug development.
• Technological advancements in imaging modalities fostering innovation in reagent formulation.
• Rising investments in research institutes and universities for preclinical studies.
• Growing awareness and incorporation of personalized medicine strategies in research and clinical applications.

By Product Type

Optical Imaging Reagents:

Optical imaging reagents are increasingly being utilized in the small animal imaging market due to their capability for high-resolution imaging and real-time monitoring of biological processes. These reagents, including fluorescent dyes and probes, are essential in visualizing cellular and molecular activities within living organisms. The advancements in optical imaging technologies have greatly expanded the applications of these reagents in preclinical studies, particularly in cancer research. The ability to track cellular dynamics and interactions in vivo provides researchers with valuable insights into tumor biology and therapeutic response, thus driving the demand for optical imaging reagents in the market.

Nuclear Imaging Reagents:

Nuclear imaging reagents play a pivotal role in the small animal imaging market, offering unique capabilities in assessing metabolic functions and biological processes at a molecular level. These reagents, typically containing radioisotopes, are widely used in positron emission tomography (PET) and single-photon emission computed tomography (SPECT). The growing prevalence of diseases such as cancer and cardiovascular disorders has led to an increased demand for nuclear imaging techniques, thereby boosting the need for nuclear imaging reagents. Their ability to provide quantitative data and facilitate the evaluation of drug efficacy in preclinical studies are key factors contributing to their market growth.

MRI Contrast Agents:

MRI contrast agents are crucial for enhancing the visibility of internal structures during magnetic resonance imaging studies in small animals. These agents, often gadolinium-based, improve the contrast of images by altering the magnetic properties of tissues. The increasing use of MRI in preclinical research, particularly in oncology and neurology studies, has resulted in a growing demand for MRI contrast agents. Their non-invasive nature and ability to provide detailed images of soft tissues make them indispensable in understanding disease progression and monitoring therapeutic responses in animal models, thereby propelling their market growth.

Ultrasound Contrast Agents:

Ultrasound contrast agents are gaining traction in the small animal imaging market due to their safety profile, cost-effectiveness, and ability to enhance the quality of ultrasound images. These agents, often consisting of microbubbles, improve the visualization of blood flow and tissue perfusion, making them valuable in cardiovascular and oncology research. The ability to perform real-time imaging with high temporal resolution supports the dynamic assessment of pathological conditions in small animals. As researchers increasingly adopt ultrasound techniques for various applications, the demand for ultrasound contrast agents is expected to rise significantly in the coming years.

CT Contrast Agents:

CT contrast agents are essential in enhancing the clarity of computed tomography images, allowing for better diagnosis and evaluation of diseases in small animals. These agents, primarily iodine-based, help delineate vascular structures and pathological lesions by increasing the density of the scanned region. The growing prevalence of chronic diseases and the need for precise imaging in preclinical studies have led to an increased adoption of CT imaging techniques, thereby boosting the demand for CT contrast agents. Their importance in providing comprehensive insights into anatomical structures and functional abnormalities contributes to their significant role in the small animal imaging reagents market.

By Application

Oncology:

The oncology segment dominates the small animal imaging reagents market, driven by the increasing prevalence of cancer and the essential role of imaging in understanding tumor biology. Imaging reagents facilitate the non-invasive monitoring of tumor development, allowing researchers to assess the efficacy of therapeutic interventions in real time. As cancer research advances, the demand for sophisticated imaging techniques that enable detailed analysis of tumor dynamics has surged, leading to a corresponding increase in the adoption of imaging reagents tailored for oncology applications. This segment is expected to continue witnessing robust growth as new cancer therapies and treatment protocols emerge, necessitating precise imaging capabilities.

Neurology:

The neurology application segment is witnessing significant growth, fueled by the rising incidence of neurological disorders and the need for effective diagnostic tools. Small animal imaging reagents are critical in studying neurodegenerative diseases, brain tumors, and other neurological conditions, providing insights into disease mechanisms and treatment responses. The increasing focus on understanding the pathophysiology of neurological diseases through preclinical studies has led to an upsurge in the demand for specialized imaging reagents that can accurately visualize brain structures and functions. This trend is expected to drive continued growth in the neurology application segment of the small animal imaging reagents market.

Cardiology:

The cardiology application segment is gaining traction due to the growing emphasis on cardiovascular research and the increasing prevalence of heart diseases. Imaging reagents play a vital role in visualizing cardiac structures, assessing blood flow, and evaluating myocardial viability in small animal models. The ability to non-invasively monitor cardiovascular functions and study the effects of different interventions is crucial for advancing cardiovascular research. As researchers continue to explore novel therapies and interventions in cardiology, the demand for imaging reagents specifically designed for cardiac applications is anticipated to rise, thereby contributing to the growth of this segment.

Inflammation:

The inflammation application segment is emerging as a significant area of focus within the small animal imaging reagents market. With the increasing recognition of the role of inflammation in various diseases, including autoimmune disorders and chronic diseases, the demand for imaging reagents that can effectively visualize inflammatory processes is on the rise. By using specific imaging techniques, researchers can monitor inflammatory responses and evaluate therapeutic efficacy in animal models. This growing interest in understanding the inflammatory response is expected to drive demand for tailored imaging reagents, thereby enhancing the growth prospects of the inflammation application segment.

Others:

The 'Others' application segment encompasses various emerging fields in which small animal imaging reagents are utilized. This includes applications in metabolic research, pharmacokinetics, and toxicology studies. As researchers explore new avenues in drug development and biological studies, the demand for specialized imaging reagents that cater to these diverse applications is expected to rise. The increasing integration of imaging techniques in preclinical research across various disciplines will further contribute to the expansion of this segment, highlighting the versatility and importance of small animal imaging reagents.

By Distribution Channel

Hospitals & Clinics:

The hospitals and clinics distribution channel represents a significant segment of the small animal imaging reagents market, primarily driven by the demand for imaging services in clinical settings. Veterinary hospitals and clinics utilize imaging reagents for diagnostic purposes, enabling them to provide accurate assessments and treatment plans for companion animals. The increasing adoption of advanced imaging technologies in veterinary medicine is fueling the demand for imaging reagents within this channel. As veterinary practices continue to evolve and embrace modern diagnostic tools, the hospitals and clinics segment is expected to experience steady growth, contributing to the overall market expansion.

Diagnostic Imaging Centers:

Diagnostic imaging centers are crucial players in the small animal imaging reagents market, providing specialized services for imaging studies. These centers often cater to both veterinary and research needs, utilizing a range of imaging modalities to conduct detailed assessments of animal health. The increasing number of diagnostic imaging facilities and their focus on adopting advanced imaging technologies are propelling the demand for imaging reagents in this channel. As diagnostic imaging centers expand their capabilities to accommodate a growing clientele, the market for small animal imaging reagents within this segment is expected to thrive.

Research Institutes:

Research institutes are significant contributors to the small animal imaging reagents market, as they are at the forefront of preclinical research and drug development. These institutes utilize imaging reagents extensively in various studies, ranging from oncology to neurology and beyond. The continuous investments in research and development, along with the increasing collaboration between academic institutions and pharmaceutical companies, are fueling the demand for imaging reagents in research settings. As research initiatives expand and new projects emerge, the research institutes segment is anticipated to witness sustained growth, underscoring the essential role of imaging reagents in advancing scientific knowledge.

Others:

The 'Others' distribution channel includes various alternative outlets for the procurement of small animal imaging reagents, such as online platforms and specialty retailers. As the demand for imaging reagents grows, the availability of these products through diverse channels is becoming increasingly important. The rise of e-commerce and online purchasing options enables researchers and veterinary clinics to access a wider range of imaging reagents conveniently. This trend towards online procurement is expected to enhance market accessibility and contribute to the growth of the 'Others' distribution channel, complementing traditional purchasing methods.

By Ingredient Type

Fluorophores:

Fluorophores are essential components in the small animal imaging reagents market, particularly for optical imaging applications. These fluorescent molecules enable researchers to visualize and monitor biological processes in living organisms with high sensitivity. The increased adoption of fluorescence imaging in preclinical research, including cancer and neurology studies, has driven the demand for fluorophores. Their versatility in various applications and the ability to be tailored for specific targets enhance their significance in the market. As researchers seek innovative ways to study complex biological phenomena, the demand for fluorophores as imaging reagents is expected to continue growing.

Radioisotopes:

Radioisotopes are pivotal in the small animal imaging reagents market, particularly in nuclear imaging techniques such as PET and SPECT. These radioactive substances provide critical insights into metabolic processes and physiological functions at a molecular level. The growing emphasis on non-invasive imaging and the rising prevalence of chronic diseases have significantly increased the use of radioisotopes in preclinical research. Their ability to generate quantitative data and facilitate the assessment of therapeutic interventions contributes to their demand in the market. As the field of nuclear medicine continues to evolve, the role of radioisotopes in small animal imaging is expected to expand further.

Gadolinium-based Compounds:

Gadolinium-based compounds are a cornerstone in the small animal imaging reagents market, particularly for MRI applications. These contrast agents enhance the visibility of soft tissues, providing researchers with detailed imaging capabilities essential for studying various diseases. The increasing utilization of MRI in preclinical studies, especially in oncology and neurology, is driving the demand for gadolinium-based compounds. Their safety and effectiveness in improving image quality make them indispensable tools for researchers. As MRI technology advances and the demand for high-resolution imaging rises, the market for gadolinium-based compounds is expected to grow accordingly.

Microbubbles:

Microbubbles serve as ultrasound contrast agents and are gaining popularity in the small animal imaging market due to their safety and effectiveness. These tiny bubbles enhance ultrasound imaging by improving the contrast of vascular structures, allowing researchers to assess blood flow and perfusion in real-time. The increasing focus on cardiovascular research and the need for non-invasive imaging techniques have propelled the demand for microbubbles. Their ability to provide dynamic imaging capabilities supports the evaluation of therapeutic outcomes, thereby contributing to the growth of the small animal imaging reagents market.

Iodine-based Compounds:

Iodine-based compounds are widely used as contrast agents in computed tomography (CT) imaging, playing a crucial role in enhancing image clarity. These compounds help delineate anatomical structures and pathological lesions during CT scans, making them valuable for diagnostic purposes. The growing prevalence of chronic diseases requiring precise imaging is driving the demand for iodine-based compounds in the small animal imaging market. As researchers seek to improve diagnostic accuracy and monitor treatment responses, the importance of iodine-based contrast agents is expected to increase, further solidifying their position in the market.

By Region

The North American region holds a significant share of the small animal imaging reagents market, primarily due to the presence of advanced research facilities and the increasing focus on preclinical research initiatives. The region's robust healthcare infrastructure, coupled with substantial investments in research and development, supports the growth of the small animal imaging market. Moreover, the rising prevalence of chronic diseases, particularly cancer, drives the demand for innovative imaging solutions. North America is expected to grow at a CAGR of 8.5% during the forecast period, reflecting a strong commitment to advancing imaging technologies and reagents.

In Europe, the small animal imaging reagents market is also witnessing notable growth, fueled by the increasing emphasis on research innovation and collaboration between academic institutions and pharmaceutical companies. The region's strong focus on healthcare and biotechnology research, along with government initiatives promoting scientific advancements, contribute to the demand for imaging reagents. The expanding applications of imaging techniques in various fields, including oncology and neurology, further enhance market growth. As European research institutions continue to invest in cutting-edge technologies, the market for small animal imaging reagents is expected to thrive, complementing the growth seen in North America.

Opportunities

The small animal imaging reagents market is poised for significant opportunities, particularly in the realm of technological advancements. The continuous evolution of imaging modalities, such as hybrid imaging techniques that combine PET with MRI or CT, presents vast potential for the development of novel reagents that can cater to these integrated approaches. Researchers are increasingly seeking imaging reagents that can provide real-time, high-resolution data, which opens up avenues for innovation in reagent design and formulation. This focus on advanced imaging technologies not only enhances the effectiveness of preclinical studies but also aligns with the growing demand for precision medicine, driving the overall market growth.

Additionally, the increasing collaboration between commercial entities and academic institutions presents a wealth of opportunities for market players. As research initiatives expand, partnerships that facilitate the development of specialized imaging reagents tailored for specific applications can significantly enhance the product offerings. Such collaborations can lead to the discovery of new biomarkers and imaging techniques that could revolutionize the field. Furthermore, the rise of personalized medicine and targeted therapies in preclinical research indicates a promising future for small animal imaging reagents, as they play a pivotal role in monitoring treatment efficacy and understanding disease mechanisms at a molecular level.

Threats

One of the primary threats to the small animal imaging reagents market is the increasing regulatory scrutiny surrounding the approval and use of imaging agents. As the demand for advanced imaging reagents rises, regulatory bodies are implementing stringent guidelines to ensure the safety and efficacy of these products. This can lead to delays in product launches and increased costs for manufacturers seeking to comply with regulations. Furthermore, the complexities involved in the development and validation of new imaging agents can deter smaller companies from entering the market, thereby limiting competition and innovation. As a result, navigating the regulatory landscape poses a significant challenge for market participants.

Another factor that may restrain market growth is the availability of alternative imaging modalities that do not require specific reagents. For instance, the growing popularity of imaging techniques that utilize AI and machine learning for image analysis may reduce the reliance on traditional imaging reagents. Researchers may opt for methodologies that leverage advanced data analytics instead of specific contrast agents, potentially impacting the demand for small animal imaging reagents. As such, the industry must adapt to these evolving trends and explore ways to demonstrate the unique advantages of imaging reagents in enhancing research outcomes.

Competitor Outlook

• Thermo Fisher Scientific
• GE Healthcare
• Biosynex
• PerkinElmer
• Bracco Imaging S.p.A
• Siemens Healthineers
• FUJIFILM Holdings Corporation
• Cardinal Health
• Miltenyi Biotec
• IVIS Imaging Systems
• Varian Medical Systems
• Medtronic
• Agilent Technologies
• Roche Diagnostics
• Merck KGaA

The competitive landscape of the small animal imaging reagents market is characterized by a mix of established players and emerging companies, each vying for market share through innovation and strategic partnerships. Major companies in the market such as Thermo Fisher Scientific and GE Healthcare leverage their extensive product portfolios and technological advancements to maintain a competitive edge. These companies are heavily invested in research and development, continuously introducing novel imaging reagents that cater to the evolving needs of researchers. Additionally, collaborations between academic institutions and industry leaders are fostering innovation, enabling the development of specialized imaging reagents that address specific research challenges.

PerkinElmer and Bracco Imaging S.p.A are notable for their contributions to the field, offering a range of imaging agents that enhance the quality and accuracy of preclinical studies. Their commitment to advancing imaging technologies through rigorous research and collaboration has positioned them as key players in the market. Furthermore, companies like Siemens Healthineers and FUJIFILM Holdings Corporation are also investing in the development of cutting-edge imaging solutions, ensuring that they remain relevant in a rapidly evolving market landscape. This competitive dynamism encourages continuous improvement and innovation across the sector.

As the market continues to grow, it is crucial for companies to stay attuned to the latest trends, such as the increasing focus on personalized medicine and the adoption of AI-driven imaging techniques. The ability to adapt and integrate these advancements into their product offerings will be paramount for success. Companies like Cardinal Health and Miltenyi Biotec are already exploring these avenues, recognizing the importance of aligning their strategies with emerging research needs. By fostering collaboration and investing in technological innovations, these companies aim to solidify their positions in the small animal imaging reagents market and cater to the diverse needs of researchers worldwide.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Biosynex
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GE Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Cardinal Health
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Miltenyi Biotec
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Agilent Technologies
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Bracco Imaging S.p.A
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 IVIS Imaging Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Siemens Healthineers
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Varian Medical Systems
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 FUJIFILM Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Small Animal Imaging Reagents Sales Market, By Application
    • 6.1.1 Oncology
    • 6.1.2 Neurology
    • 6.1.3 Cardiology
    • 6.1.4 Inflammation
    • 6.1.5 Others
  • 6.2 Small Animal Imaging Reagents Sales Market, By Product Type
    • 6.2.1 Optical Imaging Reagents
    • 6.2.2 Nuclear Imaging Reagents
    • 6.2.3 MRI Contrast Agents
    • 6.2.4 Ultrasound Contrast Agents
    • 6.2.5 CT Contrast Agents
  • 6.3 Small Animal Imaging Reagents Sales Market, By Ingredient Type
    • 6.3.1 Fluorophores
    • 6.3.2 Radioisotopes
    • 6.3.3 Gadolinium-based Compounds
    • 6.3.4 Microbubbles
    • 6.3.5 Iodine-based Compounds
  • 6.4 Small Animal Imaging Reagents Sales Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Diagnostic Imaging Centers
    • 6.4.3 Research Institutes
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Small Animal Imaging Reagents Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Small Animal Imaging Reagents Sales market is categorized based on

By Product Type

• Optical Imaging Reagents
• Nuclear Imaging Reagents
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

By Application

• Oncology
• Neurology
• Cardiology
• Inflammation
• Others

By Distribution Channel

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Research Institutes
• Others

By Ingredient Type

• Fluorophores
• Radioisotopes
• Gadolinium-based Compounds
• Microbubbles
• Iodine-based Compounds

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• GE Healthcare
• Biosynex
• PerkinElmer
• Bracco Imaging S.p.A
• Siemens Healthineers
• FUJIFILM Holdings Corporation
• Cardinal Health
• Miltenyi Biotec
• IVIS Imaging Systems
• Varian Medical Systems
• Medtronic
• Agilent Technologies
• Roche Diagnostics
• Merck KGaA